901例社区2型糖尿病血瘀证的影响因素研究

目的 了解血瘀证在社区2型糖尿病患者中的分布及其相关影响因素。 方法 以社区901例2型糖尿病患者为研究对象,采集其相关临床信息并进行中医辨证分析,采用单因素分析和Logistic回归分析考察血瘀证的影响因素。 结果 901例2型糖尿病患者中,单纯血瘀脉络证165例,阴虚热盛证、湿热困脾证、气阴两虚证、阴阳两虚证分别为137、135、334、130例,分别兼夹血瘀证55、57、200、101例,各证型兼夹血瘀证的比例明显不同（P<0.05）。单因素分析结果显示,年龄、病程、高血压并发症、收缩压、体质量、体型是血瘀证的影响因素,舒张压、血脂水平不是血瘀证的影响因素;二项分类Logistic回归分析结果显示,年龄、高血压并发症、收缩压是血瘀证的影响因素。 结论 血瘀证是社区2型糖尿病患者的主要证型,年龄越大,具有高血压并发症,收缩压较高者易于出现血瘀证,尚不能认为病程、体质量和体型是2型糖尿病血瘀证的影响因素。     

针刺配合耳穴压籽治疗2型糖尿病(肥胖型)67例

目的：观察针灸治疗2型糖尿病的临床疗效，为进一步研究其作用机制提供临床依据。方法：67例患分胃肠实热（34例），脾虚湿阻（13例）、肝郁气滞（12例）、肾气不足（8例）4型，视不同证型施以相应补泻手法，比较治疗前后血糖、胰岛素、血脂等的变化。结果：针灸在调整患糖脂代谢的同时，还可以改善其临床症状及肥胖指标。     

益气养阴活血中药改善2型糖尿病胰岛素抵抗研究

目的:探讨益气养阴活血中药改善气阴两虚血瘀型2型糖尿病患者胰岛素抵抗的机制.方法:将70例2型糖尿病胰岛素抵抗患者随机分为对照组和治疗组各35例.基础治疗均为口服格列吡嗪或达美康,治疗组在此基础上加用益气养阴活血中药.3个月为1个疗程.观察两组患者治疗前后空腹血糖(fasting blood glucose, FBG)、餐后2 h血糖(postprandial 2 hours blood glucose, P2BG)、空腹血胰岛素(fasting insulin, FINS)、糖化血红蛋白(glycosylated hemoglobin A1c, GHbA1c)、血脂、凝血功能等指标的变化,并计算稳态模型评估胰岛素抵抗(homeostasis model assessment insulin resistance,Homa-IR)指数.结果:两组患者治疗3个月后,FBG、P2BG、FINS、GHbAlc、Homa-IR及血脂、凝血指标均显著改善(P＜0.05,P＜0.01),治疗组改善程度显著优于对照组(P＜0.05,P＜0.01).治疗组降糖疗效和中医证候疗效显著优于对照组(P＜0.01).结论:益气养阴活血中药在防治和改善2型糖尿病患者的胰岛素抵抗及血脂紊乱、血液高凝状态方面具有一定的疗效.     

Peddling a semiotics of fear: a critical examination of scare tactics and commercial strategies in public health promotion

In this study, we critically examine the ways in which a nationwide health promotion campaign – the 2013 Diabetes UK/Tesco diabetes campaign, the largest of its kind in the UK – seeks to raise the general public's awareness of Type 2 diabetes. We subject a series of six campaign images (including their layout and accompanying text) to a multimodal discourse analysis, identifying the presence of a range of fear-inducing, stigmatising and commercial strategies, through which the campaign emphasises the dangers of diabetes and advocates personal responsibility for assessing both individual and others' risk of the disease. Specifically, we describe, in multi-semiotic detail, three discursive techniques deployed in the campaign to achieve these ends: (1) the depiction of grief and amplification of diabetes-related danger, (2) the promotion of diabetes risk and localisation of individuals' responsibility for their health and (3) the commercial branding and framing of the Diabetes UK/Tesco partnership – including the promotion of goods and services – as a means of diabetes prevention and management. Our findings raise concerns about the moral legitimacy of using fear-inducing and commercial strategies in order to (effectively) raise public awareness of and responses to Type 2 diabetes, strategies which do little to address the environmental factors which are associated with increasing rates of the disease.     

益化清解方对2型糖尿病大鼠炎性分子网络的影响

[HT5K]目的:观察益化清解方对2型糖尿病（T2DM）大鼠炎性分子网络调控的影响。方法:复制T2DM大鼠模型,治疗组用益化清解方中药灌胃,并与模型组、二甲双胍组及正常组作对照。分别在给药前和给药第15,30天检测T2DM大鼠的肿瘤坏死因子 α（TNF α）、白介素6(IL 6）、高敏C 反应蛋白（hsCRP）、脂联素(Adiponectin,Adp)、瘦素(leptin）水平,探讨其变化与空腹血糖（FBG）、血清胰岛素（FINS）及胰岛素敏感性指数（ISI）的关系;并检测各组大鼠脂肪组织脂联素及骨骼肌组织脂联素受体R1 Mrna表达水平,探讨Adp、Adp受体与这些因素之间的关系。结果:益化清解方能显著降低T2DM大鼠血糖、血脂、C反应蛋白等水平,并提高胰岛素敏感性,改善糖尿病大鼠的脂肪组织Adp Mrna表达水平。结论:益化清解方对糖、脂双调节的作用可能是通过增加胰岛素敏感性而实现的,其与改善糖尿病大鼠的脂肪组织Adp Mrna表达相关.     

糖尿病微血管病变从阴虚血瘀论治探析

糖尿病微血管病变属于中医学“消渴”范畴,具有现代医学微血管病变的典型特征和中医阴虚血瘀的典型证候表现。阴虚是消渴之本,血瘀是消渴之标,阴虚血瘀是其根本病机。滋阴生津、活血通脉是中医调理糖尿病微血管病变的根本途径。     

Fournier Gangrene and Unexpected Death

Abstract: Fournier gangrene represents a rare but progressive perineal infection that may result in rapid death. A 70‐year‐old man with poorly controlled diabetes mellitus and alcohol abuse is reported who was found unexpectedly dead. He had last been contacted the night before his death. At autopsy, the most striking finding was deep necrotic ulceration of the scrotum with exposure of underlying deep muscles and testicles, with blood cultures positive for Escherichia coli. Death was, therefore, attributed to necrotic ulceration/gangrene of the perineum (Fournier gangrene) that was due to E. coli sepsis with underlying contributing factors of diabetes mellitus and alcoholism. In addition there was morbid obesity (body mass index 46.9), cirrhosis of the liver, and marked focal coronary artery atherosclerosis with significant cardiomegaly. Fournier gangrene may be an extremely aggressive condition that can result in rapid death, as was demonstrated by the rapid progression in the reported case.     

Hyperosmolarity Induces Armanni‐Ebstein‐like Renal Tubular Epithelial Swelling and Cytoplasmic Vacuolization

Armanni–Ebstein lesions have been considered pathognomonic for diabetes mellitus and appear as markedly swollen renal tubular epithelial cells with cytoplasmic clearing and glycogen accumulation. However, the extent to which hyperosmolarity contributes to the Armanni–Ebstein phenotype is unclear. Ten sheep were injected intravenously with 20% mannitol at 11 mOsm/kg, and subsequent histological evaluation of the kidneys showed variable degrees of osmotic nephrosis and cytoplasmic clearing of renal tubular epithelial cells similar to that seen with Armanni–Ebstein lesions. However, although morphological changes similar to Armanni–Ebstein lesions could be produced, no intracytoplasmic glycogen was demonstrated with periodic Acid–Schiff (PAS) stain. This suggests that while hyperosmolarity may contribute to the development of an Armanni–Ebstein phenotype, glycogen accumulation may result from the more complex metabolic effects of glucose on renal tubular epithelial cells. Thus, when Armanni/Ebstein‐like vacuolizations are seen at autopsy, a confirmatory PAS stain is recommended because of the potential effect of hyperosmolar states.     

Armanni–Ebstein Lesions in Terminal Hyperglycemia

Armanni–Ebstein lesions (AEL) occur in deaths related to uncontrolled diabetes mellitus. To investigate the relationship between AEL and terminal hyperglycemia, we retrospectively reviewed 71 cases with vitreous glucose levels ≥11.1 mmol/L; 27 (38%) cases had AEL (vitreous glucose 14.0–77.3 mmol/L); and 44 cases (62%) did not (vitreous glucose 11.1–91.9 mmol/L). There was no significant difference (p = 0.271) in vitreous glucose levels between the cases with AEL (mean 39.2, SD 16.7 mmol/L) and those without (mean 34.2, SD 19.8 mmol/L). Similarly, there was no difference in the degree of dehydration, renal failure, or osmolality. However, there was a significantly higher level of β‐hydroxybutyrate among the cases with AEL compared to those without (p = 0.007), suggesting that ketoacidosis may facilitate the development of AEL. Given the possible synergistic role of β‐hydroxybutyrate, the correlation between AEL and terminal hyperglycemia in animal studies may not be applicable to humans. AEL may also possibly occur with sublethal elevations in glucose.     

Basal Vacuolization in Renal Tubular Epithelial Cells at Autopsy and Their Relation to Ketoacidosis

Basal vacuolization of renal tubular epithelial cells is a useful postmortem marker for ketoacidosis. To investigate its incidence and relationship to the severity of ketoacidosis, 158 autopsy cases with elevated β‐hydroxybutyrate (>1 mmol/L) over a 7‐year‐period were retrospectively reviewed. Sixty‐eight cases (43%) exhibited basal vacuolizations (vitreous β‐hydroxybutyrate: 1.16–29.35 mmol/L, mean 10.28 mmol/L), and 90 cases (57%) did not (vitreous β‐hydroxybutyrate: 1.03–13.7 mmol/L, mean 2.84 mmol/L). Quantitative analysis revealed on average a fourfold elevation in β‐hydroxybutyrate in cases with basal vacuolizations compared to those without; 10.3% of cases with β‐hydroxybutyrate concentrations between 1.01 and 2.00 mmol/L had basal vacuolizations, and this incidence increased to 33.3% with concentrations between 4.01 and 6.00 mmol/L. A marked increase in incidence to >70% was observed with concentrations >6.00 mmol/L, and basal vacuoles were invariably present (100%) with concentrations >14.01 mmol/L. This study demonstrates that basal vacuolizations are a sensitive marker for significant ketoacidosis and reaffirms its use as an indicator for likely cases of fatal ketoacidosis at autopsy.